CSS LLC’s Adverum Biotechnologies ADVM Stock Holding History

CSS LLC’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,400	Closed	-$25K	–	1151
2021 Q4	$25K	Hold	1,400	–	–	﹤0.01%	1155
2021 Q3	$30K	Hold	1,400	–	–	﹤0.01%	1107
2021 Q2	$49K	Buy	+1,400	New	+$75.4K	﹤0.01%	991

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CSS LLC's ADVM Position: Q1 2022 in Review

CSS LLC sold out of Adverum Biotechnologies (ADVM) in Q1 2022, closing a stake of 1,400 shares — an estimated $25K sold.

CSS LLC first reported a position in ADVM in Q2 2021 and held it in 3 quarters. The position peaked at $49K in Q2 2021. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

CSS LLC reported no remaining Adverum Biotechnologies position as of Q1 2022 after selling out during the quarter.
CSS LLC sold 1,400 Adverum Biotechnologies shares in Q1 2022, an estimated $25K.
CSS LLC first reported a position in Adverum Biotechnologies in Q2 2021 and held it in 3 quarters.
CSS LLC's Adverum Biotechnologies position peaked at $49K in Q2 2021.
92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.